BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.
Viviana NocitiMassimo SantoroDavide QuarantaFrancesco Antonio LosavioChiara De FinoRocco GiordanoNicole Piera PalombaPaolo Maria RossiniFranca Rosa GueriniMario ClericiDomenico CaputoMassimiliano MirabellaPublished in: PloS one (2018)
In patients with a high disease progression the hypomethylation of the BDNF gene could increase the secretion of the protective neurotrophin, so epigenetic modifications could be the organism response to limit a brain functional reserve loss. Our study suggests that the percentage of methylation of the BDNF gene could be used as a prognostic factor for disease progression toward a high disability in MS patient.